Clinical Trials: Epilepsy

Alabaster : 48 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Birmingham : 10 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Northport : Neurology Clinic, P.C.

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Northport : Neurology Clinic, P.C.

Eslicarbazepine Acetate Monotherapy Long Term Study

Northport : Neurology Clinic, P.C.

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

View More »

Northport : 42 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Tucson : Center for Neurosciences

Still having seizures despite taking antiepileptic medication?

View More »

Phoenix : 001 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Phoenix : 013 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Phoenix : 001 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Phoenix : St. Joseph Hospital & Medical Center/Barrow Neurology Clinic

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Phoenix : 21st Century Neurology, a division of Xenoscience, Inc.

Eslicarbazepine Acetate Monotherapy Long Term Study

Phoenix :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Phoenix : 004 Updated

Optimising Combination Therapy On Partial Onset Seizures

Phoenix : Xenoscience Inc.

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Phoenix : 001

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Phoenix :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Phoenix : United States, Arizona

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Phoenix : 151 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Phoenix : 14 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Phoenix : 9 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Sun City : Arizona Neurological Institute

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Sun City : 150 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Tucson : Center for Neurosciences

A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures

Tucson : Center for Neurosciences

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Tucson : 006 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Tucson : 006 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Tucson : University of Arizona Health Sciences Center

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Tucson : University of Arizona, Health Sciences Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Tucson : Center for Neurosciences

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Tucson : University of Arizona Health Sciences Center

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Tucson : United States, Arizona

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Tucson : 103 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Little Rock : Clinical Trials, Inc

Epilepsy and non-controlled partial seizures

Little Rock : Clinical Trials, Inc.

Epilepsy and non-controlled partial seizures

Little Rock : Clinical Trials, Inc.

Epilepsy and uncontrolled partial seizures

Little Rock : Clinical Trials, Inc.

Epilepsy and Visual Field Change Study

View More »

Conway : Arkansas Neurology

Eslicarbazepine Acetate Monotherapy Long Term Study

Conway : Arkansas Neurology

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Jonesboro : 102 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Jonesboro : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Little Rock : Arkansas Children's Hospital

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Little Rock : Arkansas Updated

A Study to Evaluate the Efficacy and Safety of VX-765 in Subjects With Treatment-Resistant Partial Epilepsy

Little Rock : 775 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Little Rock : Clinical Trials, Inc.

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Little Rock : K&S Professional Research Services, LLC

Eslicarbazepine Acetate Monotherapy Long Term Study

Little Rock : University of Arkansas for Medical Sciences

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Little Rock : K & S Professional Research Services

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Little Rock : Clinical Trials Incorporated

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Little Rock : United States, Arkansas

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Little Rock : 7 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Little Rock : 86 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Little Rock : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Aneheim : Kaiser Permanente

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Bakersfield : Kern County Neurological Medical Group, INC.

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Fresno : Neuro-Pain Medical Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Fresno : 001 Updated

Optimising Combination Therapy On Partial Onset Seizures

Fresno : Neuro-Pain Medical Center

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

View More »

Garden Grove : Collaborative Neuroscience Network

Eslicarbazepine Acetate Monotherapy Long Term Study

Garden Grove : Collaborative Neuroscience Network

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Irvine : 103 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

La Habra : 120 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Loma Linda : Faculty of Physicians and Surgeons of Loma Linda University

Eslicarbazepine Acetate Monotherapy Long Term Study

Loma Linda : Loma Linda University

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Loma Linda : Faculty of Physicians & Surgeons of Loma Linda University

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Loma Linda : United States, California

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Los Angeles : Childrens Hospital Los Angeles

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Los Angeles : VA Greater Los Angeles Healthcare System

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Los Angeles : West Los Angeles VA Medical Center

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Los Angeles : Pfizer Investigational Site Updated

Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures

Los Angeles : 59 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Los Gatos : 173 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Murriela : Viking Clinical Research

Eslicarbazepine Acetate Monotherapy Long Term Study

Murrieta : Viking Clinical Research Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Northridge : Northridge Neurological Research Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Oxnard : 030 Updated

Optimising Combination Therapy On Partial Onset Seizures

Pasadena : Yafa Minazad, DO

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Rancho Mirage : 123 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Sacramento : 025 Updated

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Sacramento :

Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy

San Francisco :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

San Francisco : 025 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

San Francisco : 025 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

San Francisco : Pfizer Investigational Site

Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures

San Francisco : 025

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

San Francisco : Pfizer Investigational Site Updated

Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures

Santa Monica : Neurological Research Institute

Eslicarbazepine Acetate Monotherapy Long Term Study

Santa Monica : Neurological Research Institute

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Santa Monica : 21 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Torrance : Collaborative Neuroscience Network

Eslicarbazepine Acetate Monotherapy Long Term Study

Torrance : Collaborative Neuroscience Network, Inc.

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Torrance : 107 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Ventura :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Ventura : Neurosearch II Inc.

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Ventura :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Ventura : United States, California

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Ventura : 159 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Venture : Neurosearch II Inc

Eslicarbazepine Acetate Monotherapy Long Term Study

Whittier : 162 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Aurora : Neurosciences Clinic - University of Colorado Hospital

Eslicarbazepine Acetate Monotherapy Long Term Study

Aurora : Anschutz Outpatient Pavilion

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Aurora : 60 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Denver : Denver Health Medical Center

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Denver : Denver Health and Hospital Authority

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

View More »

Englewood : Specialty Nuerology, PC

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Danbury : Associated Neurologists, PC

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Fairfield : 25 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Dover : 133 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Miami : Pharmax Research Clinic, Inc.

Epileptic patients with partial seizures

View More »

Atlantis : JEM Research, LLC

Eslicarbazepine Acetate Monotherapy Long Term Study

Bradenton : Bradenton Clinical Research

Eslicarbazepine Acetate Monotherapy Long Term Study

Bradenton : 025 Updated

Optimising Combination Therapy On Partial Onset Seizures

Bradenton : Bradenton Research Center, Inc.

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Brenton :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Clearwater : 156 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Coral Gables : Miami Clinical Research

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Doral : 94 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Gainesville : University of Florida

Heart Rate Changes in Subjects With Epilepsy

Gainesville :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Gainesville : 108 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Gainsville :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Gulf Breeze :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Gulf Breeze : Eisai Medical Services

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

Gulf Breeze : NW FL Clinical Research Group, LLC

Eslicarbazepine Acetate Monotherapy Long Term Study

Gulf Breeze :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Gulf Breeze : 108

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Gulf Breeze : NW FL Clinical Research Group, LLC

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Gulf Breeze :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Gulf Breeze : United States, Florida

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Gulf Breeze : 130 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Hialeah : Palm Springs Research Institute

Eslicarbazepine Acetate Monotherapy Long Term Study

Hialeah : Palm Springs Research Institute, Inc

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Hollywood : Infiniti Clinical Research, LLC

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Hollywood : 140 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Jacksonville :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Jacksonville : University of Florida Health Science Center

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Jacksonville :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Loxahatchee :

Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy

Maitland : Neurology Associates

Eslicarbazepine Acetate Monotherapy Long Term Study

Maitland : Neurology Associates, PA

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Melbourne : Melbourne Internal Medical Associates

Eslicarbazepine Acetate Monotherapy Long Term Study

Miami : Miami VA Medical Center

Compare Tolerability of an Overnight Switch to Gradual Switch Between Two Different Forms of Depakote

Miami : Miami Children's Hospital

Eslicarbazepine Acetate Monotherapy Long Term Study

Miami : Neuroscience Consultants

Eslicarbazepine Acetate Monotherapy Long Term Study

Miami :

Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy

Miami : San Marcus Research Clinic

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Miami : Miami Children's Hospital

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Miami : 123 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Miami : 132 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Miami : 143 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Ocala : 015 Updated

Optimising Combination Therapy On Partial Onset Seizures

Orlando :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Orlando : Pediatric Neurology Epilepsy Center

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Orlando : Pediatric Neurology, PA

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Orlando : Eisai Medical Services

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

Orlando : 027 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Orlando : 027 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Orlando : Pediatric Neurolog, PA

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Orlando : 77 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Ormond Beach : Neurology Associates of Ormond Beach

Eslicarbazepine Acetate Monotherapy Long Term Study

Ormond Beach : Neurology Associates of Ormond Beach

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Panama City : Bay Neurological Institute

Eslicarbazepine Acetate Monotherapy Long Term Study

Panama City : Bay Neurological Institute

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Panama City : 49 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Pensacola :

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

Pinellas Park : 109 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Port Charlotte : Medsol Clinical Research Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Port Charlotte :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Port Charlotte : Medsol Clinical Research Center

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Port Charlotte :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Port Charlotte : 129 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Sarasota : 012 Updated

Optimising Combination Therapy On Partial Onset Seizures

Sarasota : 50 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Tallahassee : Tallahasse Neurological Clinic

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Tallahassee : Tallahassee Neurological Clinic

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Tampa : 012 Updated

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Tampa :

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

Tampa : Pediatric Epilepsy & Neurology Specialists, PA

Eslicarbazepine Acetate Monotherapy Long Term Study

Tampa : Florida Comprehensive Epilepsy and Seizure Disorder Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Tampa : Pfizer Investigational Site

Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures

Tampa : 014 Updated

Optimising Combination Therapy On Partial Onset Seizures

Tampa : Florida Comprehensive Epilepsy and Seizure Disorder Center

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Tampa : Pediatric Epilepsy & Neurology Specialists, PA

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Tampa : Pfizer Investigational Site Updated

Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures

Tampa : University of South Florida

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Tampa : United States, Florida

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Tampa : 163 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Venice : Loveland Scientific Resources Inc.

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Vero Beach : Vero Neurology

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Wellington : Palm Beach Clinical Research Network, LLC

A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures

Wellington : 019 Updated

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Wellington : Palm Beach Clinical Research Network, LLC

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Wellington : 103

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Wellington : 003 Updated

Optimising Combination Therapy On Partial Onset Seizures

Wellington : Palm Beach Clinical Research Network LLC

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Wellington : United States, Florida

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Atlanta : Neurotrials Research, Inc.

Do you have Seizures?

Atlanta : Neurotrials Research, Inc.

Do you suffer from Seizures?

Atlanta : Neurotrials Research, Inc.

Do You Suffer from Seizures?

Atlanta : NeuroTrials Research, Inc.

Epilepsy - diagnosed less than 2 years

Atlanta : NeuroTrials Research, Inc.

Epilepsy - diagnosed less than 2 years

View More »

Atlanta : 023 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Atlanta : 023 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Atlanta : Emory University

Does Memantine Improve Verbal Memory Task Performance in Subjects With Left Temporal Lobe Epilepsy and Memory Dysfunction?

Atlanta : PANDA Neurology and Atlanta Headache Specialists

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Atlanta : Peachtree Neurological Clinic

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Atlanta : 112 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Atlanta : 79 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Atlanta : 167 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Atlanta : Emory Healthcare

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Augusta :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Augusta : 124 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Macon : 115 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Rome : Harbin Clinic

Eslicarbazepine Acetate Monotherapy Long Term Study

Rome : Harbin Clinic

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Rome : 118 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Suwanee : GA Neurology and Sleep Medicine Associates

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Boise :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Boise : 039 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Boise : 039 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Boise : Consultants in Epilepsy and Nuerology

Eslicarbazepine Acetate Monotherapy Long Term Study

Boise : Consultants in Epilepsy and Neurology, PLLC.

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

View More »

Boise : United States, Idaho

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Boise : 58 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Chicago : 029 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Chicago : 029 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Chicago : University of Chicago

Heart Rate Changes in Subjects With Epilepsy

Chicago : UCMC

Study the Efficacy and Safety of Diazepam Auto-injector for Controled Episodes of Acute Repetitive Seizures

Chicago : University of Illinois at Chicago

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

View More »

Chicago : United States, Illinois

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Chicago : 166 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Chicago : 57 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Flossmoor : 128 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Hines : 131 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Peoria : 005 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Peoria : 005 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Peoria : OSF Saint Francis Medical Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Peoria : OSF Saint Francis Medical Center

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Peoria : 146 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Peoria : University of Illinois College of Medicine at Peoria

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Springfield : Southern Illinois University School of Medicine

Eslicarbazepine Acetate Monotherapy Long Term Study

Springfield : Southern Illinois University

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Springfield : 11 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Winfield : 017 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Winfield : 017 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Winfield : Central DuPage Hospital

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Indianapolis : J.W.M. Neurology P.C.

Eslicarbazepine Acetate Monotherapy Long Term Study

Indianapolis : Josephson Wallack Munshower Neurology PC

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Ames : 020 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Ames : 020 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Ames : McFarland Clinic, PC

Eslicarbazepine Acetate Monotherapy Long Term Study

Ames : McFarland Clinic, PC

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Ames : 73 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

View More »

Des Moines : 130 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Manhattan : United States, Kansas

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Manhattan : 124 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Wichita :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Wichita :

Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy

Wichita : Via Christi Epilepsy Center

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

View More »

Wichita : 160 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Wichita : 23 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Bowling Green : 102 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Lexington :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Lexington : 780 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Lexington : Bluegrass Epilepsy Research, LLC

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Lexington : Bluegrass Epilepsy Research, LLC

Eslicarbazepine Acetate Monotherapy Long Term Study

View More »

Lexington : Bluegrass Epilepsy Research

Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures

Lexington :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Lexington : University of Kentucky Department of Neurology

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Lexington : Bluegrass Epilepsy Research LLC

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Lexington : 780

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Lexington :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Lexington : 119 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Lexington : 164 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Louisville :

Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy

Louisville : 62 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Louisville : University of Louisville Hospital

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Paducah : 117 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Hammond : 006 Updated

Optimising Combination Therapy On Partial Onset Seizures

Hammond : North Oaks Neurology

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Houma : Leonard J. Chabert Medical Center

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Houma : 107 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Shreveport : Louisiana State University Health Science Center - Shreveport

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

View More »

St Ruston : 145 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Baltimore : Johns Hopkins University

A Pharmacokinetic Study of a Single-Dose of DZNS in Adult Epileptic Patients Experiencing a Seizure Episode

Baltimore : John's Hopkins University School of Medicine

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Baltimore : Johns Hopkins University

Eslicarbazepine Acetate Monotherapy Long Term Study

Baltimore : John Hopkins University

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Baltimore : The Sandra and Malcom Berman Brain & Spine Institute

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

View More »

Baltimore : United States, Maryland

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Bethesda : Maryland Updated

A Study to Evaluate the Efficacy and Safety of VX-765 in Subjects With Treatment-Resistant Partial Epilepsy

Bethesda : 008 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Bethesda : 008 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Bethesda : Mid-Atlantic Epilepsy and Sleep Center

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Bethesda : Mid-Atlantic Epilepsy and Sleep Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Bethesda : Mid-Atlantic Epilepsy and Sleep Center

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Bethesda : 008

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Bethesda : Mid-Atlantic Epilepsy and Sleep Center

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Bethesda : United States, Maryland

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Waldorf :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Waldorf :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Waldorf : 137 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Boston : 030 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Boston : 030 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Boston : Massachusetts General Hospital

Cognitive Effects of Treatment of Interictal Discharges

Boston : Massachusetts General Hospital

Does Memantine Improve Verbal Memory Task Performance in Subjects With Left Temporal Lobe Epilepsy and Memory Dysfunction?

Boston : 106

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

View More »

Boston : Massachusetts General Hospital Epilepsy Service - WACC

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Boston : Beth Israel Deaconess Medical Center

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Boston : 153 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Burlington : Lahey Clinic

Eslicarbazepine Acetate Monotherapy Long Term Study

Burlington : Lahey Clinic

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Burlington : 155 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Pittsfield : 136 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Springfield : 144 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Detroit : Children's Hospital of Michigan, Neurology

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Detroit : Wayne State University/Detroit Medical Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Detroit : Wayne State University/Detroit Medical Center

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Detroit : United States, Michigan

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Detroit : 41 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Golden Valley : 009 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Golden Valley : 009 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Golden Valley : Minneappolis Clinic of Neurology

Eslicarbazepine Acetate Monotherapy Long Term Study

Golden Valley : Minneappolis Clinic of Neurology

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Golden Valley : 30 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

View More »

Minneapolis : GSK Investigational Site

Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and Its N-acetyl Metabolite

Minneapolis : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

St Paul : 006 Updated

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

St. Paul : Minnesota Epilepsy Group, P.A.

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

St. Paul : 101

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

St. Paul : University of Minnesota & Prism Research

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

St. Paul : United States, Minnesota

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Flowood : Biomedical Research Alliance of New York

Partial Epilepsy

View More »

Flowood : Precise Research Centers

Eslicarbazepine Acetate Monotherapy Long Term Study

Flowood : Precise Research Centers

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Saint Louis : Washington University in St. Louis - Center for Clinical Studies

Volunteers with epilepsy are needed for a genetic study at Washington University School of Medicine.

View More »

Chesterfield :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Chesterfield : 040 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Chesterfield : The Comprehensive Epilepsy Care Center for Children & Adults

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Chesterfield : Comprehensive Epilepsy Care Center for Children and Adults

Eslicarbazepine Acetate Monotherapy Long Term Study

Chesterfield :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Chesterfield : 113

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Chesterfield : The Comprehensive Epilepsy Care Center for Children and Adults

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Chesterfield : The Comprehensive Epilepsy Care Center for Children and Adults

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Chesterfield :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Chesterfield : United States, Missouri

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Chesterfield : 31 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Kansas City : 008 Updated

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Kansas City : 151 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Springfield : 023 Updated

Optimising Combination Therapy On Partial Onset Seizures

St Louis :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

St. Louis : PsychCare Consultants Research

Eslicarbazepine Acetate Monotherapy Long Term Study

St. Louis : PsychCare Consultants Research

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

St. Louis :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Omaha : 174 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Lebanon : 032 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Lebanon : 032 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Cherry Hill : Cooper University Health System

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Edison : 43 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Gibbsboro : United States, New Jersey

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Hackensack :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Hackensack : Northeast Regional Epilepsy Group

Cognitive and Behavioral Effects of Lacosamide

View More »

Hackensack : Northeast Regional Epilepsy Group

Effect on Anxiety in Partial Epilepsy Patients Treated With Pregabalin

Hackensack : Marcelo Lancman, MD

Eslicarbazepine Acetate Monotherapy Long Term Study

Hackensack :

Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy

Hackensack : Northeast Regional Epilepsy Group

Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures

Hackensack : Northeast Regional Epilepsy Group

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Livingston : Institute of Neurology and Neurosurgery at St. Bamabas, Suite 101

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

New Brunswick : 015 Updated

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

New Brunswick : University Medicine and Dentistry of New Jersey

Eslicarbazepine Acetate Monotherapy Long Term Study

New Brunswick : University of Medicine and Dentistry of New Jersey

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Newark : UMDNJ

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Newark : Umdnj-Ubhc

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Newark : University Hospital Pharmacy

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Newark : University of Medicine and Dentistry of New Jersey

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Newark : UMDNJ DOC 8th Floor 8100

Eslicarbazepine Acetate Monotherapy Long Term Study

Newark : UMDNJ DOC 8th Floor 8100

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Paterson : St. Jospeph's Regional Medical Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Paterson : St. Joseph's Regional Medical Center

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Paterson : 114 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Princeton : Global Medical Institutes, LLC

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Toms River : Shore Neurology, PA

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Voorhees : Clinical Research Center of New Jersey

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Voorhees : Eisai Medical Services

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

Voorhees : 037 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Voorhees : 67 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Bronx : Biomedical Research Alliance of New York

Epilepsy - Adults

Bronx : Biomedical Research Alliance of New York

Epliepsy - Adults

Great Neck : Biomedical Research Alliance of New York

Are you taking Lamotrigine (Lamictal) or Valproic Acid (Depakote/Depakene)?

Great Neck : Biomedical Research Alliance of New York

Women with Epilepsy: Pregnancy Outcomes and Deliveries

New York : Biomedical Research Alliance of New York

Epilepsy - Adults

New York : Biomedical Research Alliance of New York

Women with Epilepsy: Pregnancy Outcomes and Deliveries

View More »

Albany :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Albany : United States, New York

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Albany : 36 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Bronx : Montefiore Medical Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Bronx : Montefiore Medical Center

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Bronx : Montefiore Medicical Center

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Bronx : United States, New York

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Brooklyn : 109 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Buffalo :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Buffalo : 105

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Cedarhurst : Five Towns Neuroscience Research

Eslicarbazepine Acetate Monotherapy Long Term Study

Cedarhurst : Five Towns Neuroscience Research

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Cedarhurst : 69 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Mineola : 154 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

New York : 022 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

New York : Clinilabs, Inc.

Eslicarbazepine Acetate Monotherapy Long Term Study

New York : Weill Medical College of Cornell University

Lexapro for Major Depression in Patients With Epilepsy

New York : Beth Israel Medical Center

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

New York : Columbia University Medical Center: Dept of Neurology

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

New York : United States, New York

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

New York : 122 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

New York : Columbia University

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Orchard Park : Dent Neurologic Institute

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Rochester : University of Rochester

Eslicarbazepine Acetate Monotherapy Long Term Study

Rochester : 104

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Rochester : University of Rochester

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Rochester : University of Rochester

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Schenectady : Schenectady Neurological Consultants, PC

A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures

Schenectady : 175 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Syracuse : 016 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Syracuse : 016 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Syracuse : SUNY Upstate Medical University Department of Neurology

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Syracuse : 016

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Syracuse : SUNY Upstate Medical University

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

West Seneca : 127 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Charlotte : PMG Research of Charlotte

Partial Epilepsy

Charlotte : PMG Research of Charlotte

Pneumonia Vaccine

Wilmington : PMG Research of Wilmington

Epilepsy: Research Study

View More »

Asheville : North Carolina Updated

A Study to Evaluate the Efficacy and Safety of VX-765 in Subjects With Treatment-Resistant Partial Epilepsy

Asheville : 010 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Asheville : 010 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Charlotte : North Carolina Updated

A Study to Evaluate the Efficacy and Safety of VX-765 in Subjects With Treatment-Resistant Partial Epilepsy

Charlotte :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Charlotte : The Neurology Institute

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Charlotte :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Charlotte : 158 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Durham : 003 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Durham : 003 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Durham : Pfizer Investigational Site

Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures

Durham : 003

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Durham : Pfizer Investigational Site Updated

Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures

Durham : United States, North Carolina

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Greenville : East Carolina Neurology

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Hickory : PMG Research of Hickory, LLC

Eslicarbazepine Acetate Monotherapy Long Term Study

Hickory : PMG Research of Hickory, LLC

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Wilmington : 117 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Wilmington : Kendle International, Inc.

UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry)

Winstom-Salem : Wake Forest University

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Winston-Salem : Department of Neurology

Eslicarbazepine Acetate Monotherapy Long Term Study

Winston-Salem : Wake Forest University Health Sciences

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Bismarck : 139 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Akron : Akron Children's Hospital

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Akron :

Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy

Akron : 002 Updated

Optimising Combination Therapy On Partial Onset Seizures

Akron : 134 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Canton : Ohio Clinical Research Partners, LLC

Eslicarbazepine Acetate Monotherapy Long Term Study

View More »

Canton : Ohio Clinical Research Partners, LLC

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Canton : 150 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Cleveland : 034 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Cleveland : 034 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Cleveland : Cleveland Clinic

Randomized Controlled Trial to Assess Effects of Lacosamide on Sleep and Wake in Adults With Focal Epilepsy

Cleveland : University Hospitals Case Medical Center

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Cleveland : Cleveland Clinic

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Columbus : 024 Updated

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Columbus : 778 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Columbus : 111

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Columbus : 022 Updated

Optimising Combination Therapy On Partial Onset Seizures

Columbus : 778

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Columbus : United States, Ohio

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Columbus : 61 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Dayton : 005 Updated

Optimising Combination Therapy On Partial Onset Seizures

Toledo : 002 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Toledo : The University of Toledo

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Toledo : 002

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Toledo : 2 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Oklahoma City : Lynn Health Science Institute

Eslicarbazepine Acetate Monotherapy Long Term Study

Oklahoma City : Lynn Health Science Institute

Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures

Oklahoma City : 013 Updated

Optimising Combination Therapy On Partial Onset Seizures

Oklahoma City : 5929 N. May Ave.

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Oklahoma City : Lynn Health Science Institute

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

View More »

Oklahoma City : United States, Oklahoma

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Oklahoma City : 147 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Tulsa :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Tulsa : Tulsa Clinical Research LLC

Eslicarbazepine Acetate Monotherapy Long Term Study

Tulsa : 018 Updated

Optimising Combination Therapy On Partial Onset Seizures

Tulsa : Tulsa Clinical Research LLC

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Tulsa : 141 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Portland :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Portland : The Neurological Clinic/The Oregon Clinic

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Portland : 157 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Abington : Biomedical Research Alliance of New York

Partial Epilepsy

View More »

Greensburg : 100 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Indiana : 121 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Philadelphia : 001 Updated

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Philadelphia : Thomas Jefferson University

A Pharmacokinetic Study of a Single-Dose of DZNS in Adult Epileptic Patients Experiencing a Seizure Episode

Philadelphia : 015 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Philadelphia : Thomas Jefferson University

Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death

Philadelphia : Thomas Jefferson University Comprehensive Epilepsy Center

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Philadelphia : University of Pennsylvania Health System

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Philadelphia : Thomas Jefferson University

Eslicarbazepine Acetate Monotherapy Long Term Study

Philadelphia : Drexel University College of Medicine, Dept of Neurology

Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia

Philadelphia : Children's Hospital Philadelphia

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Philadelphia : Drexel University College of Medicine

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Philadelphia : Thomas Jefferson University

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Philadelphia : Temple University School of Medicine

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Philadelphia : Temple University Health systems

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Philadelphia : United States, Pennsylvania

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Philadelphia : 159 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Philadelphia : 32 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Philadelphia : Hospital University of PA

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Philadelpia : Temple University School of Medicine, Dept of Neurology

Eslicarbazepine Acetate Monotherapy Long Term Study

Pittsburg : Children's Hospital of Pittsburg of UPMC

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Pittsburgh : 016 Updated

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Pittsburgh : Children's Hospital of Pittsburgh of UPMC

Eslicarbazepine Acetate Monotherapy Long Term Study

Pittsburgh : 114

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Beaufort : 021 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Beaufort : 021 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Charleston : 028 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Charleston : 028 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Charleston : Medical University of South Carolina

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

View More »

Columbia : 120 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Orangeburg : 149 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Spartanburg : 152 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Chattanooga : 114 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Mountain Home : 171 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Nashville : 004 Updated

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Nashville : Vanderbilt University

A Pharmacokinetic Study of a Single-Dose of DZNS in Adult Epileptic Patients Experiencing a Seizure Episode

Nashville : 776 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

View More »

Nashville : VU Department of Neurology

Eslicarbazepine Acetate Monotherapy Long Term Study

Nashville : 109

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Nashville : VU Department of Neurology

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Nashville : 776

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Nashville : United States, Tennessee

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Nashville : 1 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Nashville : Vanderbilt University Medical Center

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Dallas : Texas Neurology, PA

Double blind, randomized, historical control study of the safety and efficacy of Eslicarbazepine Acetate Monotherapy in subjects with partial epilepsy not well controlled by current antiepileptic drugs

Dallas : Texas Neurology, PA

Efficacy and Safety of Eslicarbazepine Acetate as adjunctive Therapy for refractory partial seizures in a double blind, randomized, placebo-controlled, parallel-group multicenter clinical trial

View More »

Arlington : Neurology Associates of Arlington, P.A.

Eslicarbazepine Acetate Monotherapy Long Term Study

Arlington : Neurology Associates of Arlington, PA

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Austin : 026 Updated

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Austin : Community Clinical Research Inc.

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Austin : 148 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Austin : 138 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Bownwood : Edwin A Green, Jr., MD

Eslicarbazepine Acetate Monotherapy Long Term Study

Brownwood : Brownwood Regional Medical Center

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Dallas :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Dallas : 011 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Dallas : 035 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Dallas : 011 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Dallas : 777 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Dallas : Neurological Clinic of Texas, P.A.

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Dallas : Neurological Clinic of Texas, P.A.

Eslicarbazepine Acetate Monotherapy Long Term Study

Dallas : Texas Neurology, PA

Eslicarbazepine Acetate Monotherapy Long Term Study

Dallas :

Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy

Dallas :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Dallas : Neurological Clinic of Texas P.A.

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Dallas : MD

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Dallas : 777

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Dallas : Neurological Clinic of Texas, P.A.

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Dallas :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Dallas : United States, Texas

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Dallas : 154 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Dallas : 111 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Dallas : 22 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Fort Worth : United States, Texas

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Houston :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Houston : The University of Texas-UT Health

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Houston : MD

Eslicarbazepine Acetate Monotherapy Long Term Study

Houston : Baylor College of Medicine

Eslicarbazepine Acetate Monotherapy Long Term Study

Houston : Pfizer Investigational Site

Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures

Houston : Todd Swick, MD, PA

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Houston : Pfizer Investigational Site Updated

Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures

Houston : 53 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Houston : 51 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Houston : Texas Children's Hospital

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Mansfield : Neurology Associates of Arlington, PA

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

San Antonio : Road Runner Research

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

San Antonio : Clinical Trials of Texas, Inc.

ECG Vector Determination

San Antonio : Innovative Clinical Trials

Eslicarbazepine Acetate Monotherapy Long Term Study

San Antonio : Road Runner Research

Eslicarbazepine Acetate Monotherapy Long Term Study

San Antonio : Pfizer Investigational Site

Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures

San Antonio : Clinical Trials of Texas, Inc.

Physiological and Biomechanical Data Collection Study in Epilepsy Subjects

San Antonio : Pfizer Investigational Site Updated

Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures

San Antonio : 98 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Spring : 022 Updated

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Temple : Scott and White Memorial Hospital

Eslicarbazepine Acetate Monotherapy Long Term Study

Temple :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Temple : Scott and White Memorial Hospital

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Temple : Scott & White Memorial Hospital

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Temple :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Tomball : 146 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Layton : 136 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Charlottesville : 036 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Charlottesville : 036 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Charlottesville : University of Virginia

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Charlottesville : 036

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Charlottesville : University of Virginia

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

View More »

Charlottesville : 16 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Fredericksburg : 119 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Norfolk : 020 Updated

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Norfolk : Sentara Neurology Specialists

Eslicarbazepine Acetate Monotherapy Long Term Study

Norfolk :

Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy

Norfolk : Sentara Neurology Specialists

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Norfolk : United States, Virginia

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Richmond :

Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy

Richmond : VCU Medical Center

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Richmond : 106 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Richmond : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Bellevue : Neurological Associates of Washington

Eslicarbazepine Acetate Monotherapy Long Term Study

Bellevue : Neurological Associates of Washington/Clinical Trials of America Inc.

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Renton : Rainier Clinical Research Center Inc.

Eslicarbazepine Acetate Monotherapy Long Term Study

Renton : Rainier Clinical Research Center, Inc.

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Renton : 74 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

View More »

Seattle : 033 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Seattle : Pacific Medical Centers

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Madison :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Madison : University of Wisconsin School of Medicine, Department of Neurology

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Madison : American Family Children's Hospital

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Madison : United States, Wisconsin

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Madison : 80 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

View More »

Marshfield : Marshfield Clinic

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Marshfield : United States, Wisconsin

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Milwaukee : Regional Epilepsy Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Milwaukee :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Milwaukee : Regional Epilepsy Center

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Milwaukee :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Milwaukee : St. Luke's Milwaukee

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Buenos Aires : CEMIC

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Buenos Aires : Centro Neurológico de Tratamiento y Rehabilitación

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Buenos Aires : Hospital Italiano de Buenos Aires

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Buenos Aires : Hospital Privado de la comunidad de Mar de Plata

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Buenos Aires :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

View More »

Buenos Aires :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Capital Federal : Hospital Ramos Mejía

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Capital Federal : Hospital Británico

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Capital Federal : Instituto Médico Especializado (IME)

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Capital Federal : Fleni

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Cordoba : Hospital Privado - Centro Médico de Córdoba S.A.

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Cordoba : Centro de Neurologia y Neurorehabilitacion

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Cordoba :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Cordoba :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Guaymallen :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Guaymallen :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Salta :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Salta :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Adelaide : 420 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Bedford Park :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Bedford Park :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Capmerdown : 421 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Chatswood : 104

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

View More »

Chatswood : 425 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Clayton :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Clayton : 105

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Clayton :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Clayton : 429 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

East Gosford : 106

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Fitzory :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Fitzory :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Fitzroy : 101

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Fitzroy : 428 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Heidelberg West :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Heidelberg West :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Heidelberg West : Australia, Vctoria

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Herston : 103

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Herston : 423 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Melbourne : Royal Melbourne Hospital

Seizure Advisory System Feasibility Study

Melbourne : St. Vincent's Hospital (Melbourne)

Seizure Advisory System Feasibility Study

Melbourne : Austin Health

Seizure Advisory System Feasibility Study

Parkville : 427 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Randwick :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Randwick :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Westmead : 102

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Woodville :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Woodville : 100

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Woodville :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Graz :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Innsbruck :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Innsbruck : 202 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Innsbruck : Universitätsklinik für Neurologie; Arbeitsgruppe Epileptologie

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Inssbruck : 202 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

View More »

Linz : 201 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Salzburg :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Salzburg : 12 Updated

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

Salzburg : Universitätsklinik für Neurologie; Christian-Doppler-Klinik

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Vienna : Universitätsklinik für Kinder- und Jugendheilkunde, Klinische Abteilung für allg. Pädiatrie, AKH Wien

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Wien :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Wien : 203 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Wien : 200 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Wien : Medizinische Universitat Wien Klinik fur Neurologie

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Wien : 503 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Antwerpen : 230 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Antwerpen : 132

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Brugge : 127

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Brussels : 225 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Brussels :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

View More »

Brussels : 202

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Brussels : 203

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Duffel : 133

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Gent :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Gent : 131

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Ghent : University Hospital Ghent

Controlled Randomized Stimulation Versus Resection (CoRaStiR)

Hasselt : 128

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Hechteleksel : 226 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Kortrijk : 130

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Leuven : 227 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Leuven : 227 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Leuven :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Leuven : 201

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Leuven : 126

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Liege : 228 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Ottignies : Clinique Saint-Pierre

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Ottignies : Centre Neurologique William Lennox

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Roeselare : 229 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Wilrijk : AZ. Sint-Augustinus

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Yvoir : Service de Neurologie; Clinique Universitaire UCL de Mont Godinne

Efficacy and Safety of Eslicarbazepine Acetateas Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures

Belo Horizonte : Santa Casa de Misericórdia de Belo Horizonte

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Campinas : Hospital das Clínicas - UNICAMP

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Curitiba : Instituto de Neurologia de Curitiba

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Porto Alegre : Hospital São Lucas - PUCRS

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Porto Alegre : Hospital de Clínicas de Porto Alegre

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

View More »

Ribeirão Preto : Hospital das Clinicas da FMRP

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Sao Paulo : Hospital São Paulo - UNIFESP

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

São Paulo : Hospital Brigadeiro

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

São Paulo : Irmandade da Santa Casa de Misericórdia de São Paulo

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Blagoevgrad : Multiprofile Hospital for Active Treatment "Pulse," AD, Town of Blagoegrad

Eslicarbazepine Acetate Monotherapy Long Term Study

Blagoevgrad : Multirprofile Hospital for Active Treatment "Pulse," AD, town of Blagoevgrad

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Blagoevrad : 703 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Pleven : Univesity Multiprofile Hospital for Active Treatment "Dr. George Stranski," EAD, town of Pleven

Eslicarbazepine Acetate Monotherapy Long Term Study

Pleven : University Multiprofile Hospital for Active Treatment "Dr. Georgi Stranski," EAD, town of Pleven

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

View More »

Pleven : 706 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Plovdiv : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Ruse 7002 : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Sofia : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Sofia : Second Multiprofile Hospital for Active Treatment

Eslicarbazepine Acetate Monotherapy Long Term Study

Sofia : 4 MHAT Sofia

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Sofia : UMHAT "Aleksandrovska"

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Sofia : UMHAT "Tsaritsa Yoanna -ISUL"

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Sofia : Diagnostic & Consultative Center "Sveta Anna" EOOD

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Sofia : First MHAT-Sofia

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Sofia : Second Multiprofile Hospital for Active Treatment - Sofia, AD, city of Sofia Neurology Department

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Sofia : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Sofia : 708 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Sofia : 700 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Sofia : 702 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Sofia : 704 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Sofia : 705 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Sofia : 707 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Sofia : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Stara Zagora : MHAT "Prof. Stoyan Kirkovich"

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Varna : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Varna : Diagnostic and Consultative Center "Equita" EOOD, town of Varna Neurology office

Eslicarbazepine Acetate Monotherapy Long Term Study

Varna : Diagnostic and Consultative Center "Equita" EOOD, town of Varna

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Varna : 701 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Calgary : 075 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Calgary : 075 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Calgary : 155

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Calgary : 127 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Greenfield Park : 077 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

View More »

Greenfield Park : 077 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Greenfield Park : Neuro-Epilepsy Clinic/ Neuro Rive-Sud

Eslicarbazepine Acetate Monotherapy Long Term Study

Greenfield Park : 152 Updated

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Greenfield Park :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Greenfield Park : Neuro-Epilepsy Clinic

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Greenfield Park : 152

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Greenfield Park :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Greenfield Park : 91 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Halifax : 140 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Hamilton : 156

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Hamilton : 116 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

London : 078 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

London : 078 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

London : London Health Sciences Centre, University Campus

Eslicarbazepine Acetate Monotherapy Long Term Study

London : London Health Sciences Center

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

London : 93 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Montreal : 079 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Montreal : 110 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Montreal : 113 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Saskatoon : 080 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Saskatoon : 080 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Sherbrooke : Centre Hospitalier Universitaire de Sherbrooke

Eslicarbazepine Acetate Monotherapy Long Term Study

Sherbrooke : Centre Hospitalier Universitaire de Sherbrooke

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

St John's : 153

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Toronto : 076 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Toronto : 076 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Toronto : 154

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Toronto : Canada, Ontario

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Santiago :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Santiago :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Valdivia :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Valdivia :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Beijing : 9

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Beijing : 1

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Changchun : 12

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Chengdu : 6

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Chongqing : 10

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

View More »

Guangzhou : 16

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Guangzhou : 4

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Guangzhou : 5

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kunming : 13

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Qingdao : 14

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Shanghai : 2

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Shanghai : 3

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Taiyuan : 15

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Wuhan : 8

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Xi'an : 7

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

San Jose : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Osijek : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Osijek : Clinical hospital Osjek Pediatric clinic, neuropediatric department

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Požega : General County Hospital Požega, Neurology department

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Rijeka : Polyclinic for neurology and psychiatry 'Interneuron

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Split : Clinical Hospital Centre Split

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

View More »

Zagreb : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Zagreb : Clinic for Children Diseases - Klinika za dječje bolesti Zagreb

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Nikosia : The Cyprus Institute of Neurology

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Brno : Clinic of the Child Neurology, FN Brno

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Brno : 505

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Brno : Neurologická klinika, FN u Sv. Anny

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Brno : 917

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Brno : 185

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

View More »

Brno - Cerna pole : Fakultni nemocnice Brno - Detska nemocnice

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Hradec Kralove : 915 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Hradec Kralove : 502

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Hradec Kralove : 915

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Hradec Králové : Neurology Policlinic

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

HradecKralove :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Kolejni : Neurologicka ordinance

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Koterova : Poradna pro epilepsie

Eslicarbazepine Acetate Monotherapy Long Term Study

Koterova : Poradna pro epilepsie

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Kromeriz : 916 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Kromeriz : 916

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Ostrava : 251 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Ostrava : 251 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Ostrava : Cerebrovaskularni poradna s.r.o.

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Ostrava - Třebovice : NZZ BORMED s.r.o.

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Ostrava Poruba : 913 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Ostrava Poruba : 913 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Ostrava Poruba : 913

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Ostrava Porubo : 504

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Ostrava-Trebovice :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Plzeň : Neurologická ambulance

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Praha : Evzen Nespor

Eslicarbazepine Acetate Monotherapy Long Term Study

Praha :

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Praha 1 : 252 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Praha 1 : 252 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Praha 10 : Clintrial, s.r.o.

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Praha 2 :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Praha 4 : 253 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Praha 4 : 253 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Praha 4 : Department of the Child Neurology FTN

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Praha 4 : 501

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Praha 4 : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Praha 4 - Krč : Fakultní Thomayerova nemocnice s poliklinikou, Neurologická klinika

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Praha 5 : Fakultni nemocnice v Motole

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Praha 5 : Children Neurology Clinic, University Hospital Motol

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Praha 6 : Neurologicka ordinance

Eslicarbazepine Acetate Monotherapy Long Term Study

Praha 6 : Medical Services Prague s.r.o.

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Praha 8 : Oddělení neurologie, FN Bulovka

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Rychnov nad Kneznou : CTC Rychnov nad Kneznou

Eslicarbazepine Acetate Monotherapy Long Term Study

Rychnov nad Kneznou : CTC Rycnov nad Kneznou

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Smetanova : Policlinic Chocen, Private Neurology

Eslicarbazepine Acetate Monotherapy Long Term Study

Smetanova : Policlinic Chocen, private neurology

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Trebovicka : Cerebrovaskularni poradna s.r.o

Eslicarbazepine Acetate Monotherapy Long Term Study

Zlin : 250 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Zlin : 250 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Zlin : 180

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Aarhus : 223 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Copenhagen : 220 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Holstebro : 222 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Tallinn :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Tartu :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Helsinki : 205

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Helsinki : 400 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Kuopio : 275 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Kuopio : 207

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Oulu : 278 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

View More »

Oulu : 402 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Seinajoki : 204

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Tampere : 276 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Tampere : 401 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Turku : 277 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Amiens : CHU Hopital Nord

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Bethune : 301 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Bethune : 301 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Bordeaux :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Bordeaux : CENTRE HOSPITALIER PELLEGRIN, CHU de BORDEAUX

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

View More »

Bordeaux : Hopital Pédiatrique Enfants

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Bron : Hopital Femme-Mere-Enfant, Hospices Civils de Lyon

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Bron : 402 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Dijon : 303 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Dijon : 404 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Garches :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Lille :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Lille : Hopital Roger Salengro, Chru de Lille

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Lille : CHRU

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Limoges : GSK Investigational Site Updated

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Limoges : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Marseille : 304 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Marseille : Hopital Enfants de la Timone

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Marseille : 613 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Marseille cedex 05 :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Montpellier : 305 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Montpellier : Hopital Gui de Chauliac, Chu de Montpellier

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Montpellier : Hopital Gui de Chauliac

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Montpellier : 406 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Montpellier Cedex 05 : Hôpital Gui de Chauliac, Explorations neurologiques et d'épileptologie

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Nancy : Hopital Central, Chu de Nancy

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Nancy : Hôpital Central - Service de Neurologie

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Nancy cedex : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Paris :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Paris : Centre Hospitalier Sainte-Anne

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Paris : Université Paris Descartes, Hopital Necker-Enfants Malades, Département de Neuropédiatrie

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Paris Cedex 13 : Groupement Hospitalier Universitaire Est, Pitié-Salpétrière; Clinique des Maladies du Système Nerveux

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Ramonville Saint Agne : 405 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Rennes : Hopital Pontchaillou, Chru de Rennes

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Rennes : 401 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Rennes Cedex : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Rouen :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Saint Priest en Jarez : 300 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Strasbourg : Hopital Civil, Chru de Strasbourg

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Strasbourg : Centre Référent des Epilepsies Rares Service de Pédiatrie 1 CHU de Hautpepierre

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Strasbourg : 610 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Strasbourg : 612 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Strasbourg Cedex : GSK Investigational Site Updated

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Strasbourg Cedex : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Toulon : 611 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Toulouse : Hopital des Enfants

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Altenburg : 263

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Aschaffenburg : 258

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Bad Neustadt : 265

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Berlin : 325 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Berlin : 329 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

View More »

Berlin : 270

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Berlin : 262

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Berlin : 257

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Berlin : 465 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Berlin : Epilepsieklinik Tabor - Ladeburger Straße 15

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Bernau : 326 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Bernau : 326 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Bielefeld :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Bielefeld : 332 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Bielefeld : 2 Updated

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

Bielefeld : 332

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Bielefeld : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Bielefeld : 463 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Bonn : UKB Universitätsklinikum Bonn

Controlled Randomized Stimulation Versus Resection (CoRaStiR)

Bonn : 1 Updated

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

Bonn :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Bonn : Klinik für Epileptologie Universität Bonn

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Bonn : 903

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Bonn :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Celle : 266

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Dresden : 4 Updated

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

Dresden : 267

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Erlangen : 5 Updated

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

Erlangen : Zentrum Epilepsie Erlangen

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Freiburg : Universitätsklinikum Freiburg

Controlled Randomized Stimulation Versus Resection (CoRaStiR)

Freiburg : Albert-Ludwigs-Universität Freiburg

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Goettingen : 331 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Goettingen : 331 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Göttingen : 260

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Hamburg : Private practice (Schomburgstr. 120)

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Kehl-Kork :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Kehl-Kork : 904 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Kehl-Kork : Epilepsiezentrum Kehl-Kork Kinderklinik Anfallsambulanz für Kinder und jugendliche

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Kehl-Kork : Diakonie Kork, Epilepsiezentrum

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Kiel : 327 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Kiel : Klinik für Neuropädiatrie Universitäts-Kinderklinik

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Kiel : Universitatsklinikum Schleswig-Holstein Campus Kiel

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Koln : Universitätskinderklinik Köln Ambulanz für Anfallsleidende

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Leipzig : 269

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Luebeck : Pediatrics Department, University of Luebeck

Transcranial Direct Current Stimulation (tDCS) As A Tool For Prospective Responder Identification Before Vagus Nerve Stimulation (VNS) Implantation

Mainz : IZKS; Universitätsmedizin der Johannes-Gutenberg-Universität Mainz

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Mainz : 461 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Marburg : 900 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Marburg : 256

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Marburg : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Muenchen : 264

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Munchen :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

München : 3 Updated

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

München : Studienzentrum Dr. Stephan Arnold

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Munich :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Münster : 261

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Osnabruck : 259

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Osnabruck : 462 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Ravensburg : 330 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Stuttgart : Neurologische Gemeinschaftspraxis am Seelberg

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Stuttgart : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Tuebingen : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Ulm :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Ulm : 328 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Ulm : 328 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Ulm : Universitäts- und Rehabilitationskliniken Ulm (RKU), Klinik für Neurologie

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Ulm : 466 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Westerstede : 913 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Alexandroupoli : 529 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Athens : 521 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Heraklion : 522 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Thessaloniki :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Thessaloniki : General Hospital of Thessaloniki "Papanikolaou"

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

View More »

Thessaloniki : Agios Loukas (St. Luke's) Hospital

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Thessaloniki :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Thessaloniki :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Thessaloniki : 520 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Thessaloniki : 527 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Thessaloniki : 524 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Thessalonikis : 490

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Guatemala : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Guatemala ciudad : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Budapest : Semmelweis Egyetem, I. Sz. Gyermekgyogyaszati Klinika

A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures

Budapest : Heim Pal Gyermekkorhaz, Neurologiai Osztaly

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Budapest : Semmelweis Egyetem, I. Sz. Gyermekgyogyaszati Klinika

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Budapest : Magyarorszagi Reformatus Egyhaz Bethesda Gyermekkorhaz, Gyermekneurologia

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Budapest :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

View More »

Budapest : Budai Gyermekkórház, Buda Children's Hospital and Outpatient Clinic

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Budapest : 283

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Budapest : 284

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Budapest : 753 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Budapest : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Debrecen :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Debrecen : 286

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Debrecen : 750 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Gyor : 282

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Hodmezovasarhely : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Kecskemet : 752 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Miskolc :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Miskolc : Children Neurology Dept., Borsod-Abaúj-Zemplén Megyei Kórház és Egyetemi Oktató Kórház

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Nyiregyhaza : 287

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Pecs :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Pecs : 288

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Pecs : 751 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Pécs : Pécsi Tudományegyetem AOK Gyermekklinika

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Szeged : 285

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Bangalore : 726 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Bangalore : 726 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Bangalore : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Bangalore : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Bangalore, : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

View More »

Hyderabad : 727 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Hyderabad : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Hyderbad : 727 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Lucknow : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Madurai : 729 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Madurai : 729 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Mangalore : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Mumbai : 725 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Mumbai : 728 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Mumbai : 725 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Nashik : 731 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Nashik : 731 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Pune : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Secunderabad : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Visakhapatnam : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Visakhapatnam : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Ashkelon :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Ashkelon :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Holon :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Holon :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Nahariya :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

View More »

Nahariya :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Petach Tikva :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Petach Tikva :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Ramat Gan :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Ramat Gan :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Bologna :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Bologna : GSK Investigational Site Updated

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Bologna : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Bologna : 442 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Brescia :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

View More »

Brescia : 440 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Cagliari : 313

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Catanzaro : 449 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Faenza : 552 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Ferrara : 443 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Firenze : 380 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Firenze :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Foggia : Azienda Ospedaliero, Universitaria "Ospedali Riuniti", Clinica della Malattie del Sistema Nervoso, Università di Foggia

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Foggia : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Gallarate : 546 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Genova : Ospedale Petiatrico IRCCS

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Genova Voltri : GSK Investigational Site Updated

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Genova Voltri : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Mantova :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Mantova : A. O. C. "Poma"

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Messina : A.O.U Policlinico di Messina

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Milano : 379 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Milano : 379 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Milano :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Milano : 441 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Monserrato : 377 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Napoli : Università degli Studi di Napoli Policlinico Federico II

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Napoli : 541 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Novara : Azienda Ospedaliero - Universitaria Maggiore della Carità

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Pavia :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Pavia : Istituto Neurologico Casimiro Mondino

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Pavia : Fondazione Istituto Neurologico Casimiro Mondino

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Perugia : 376 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Perugia : 376 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Perugia : 450 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Pisa : 375 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Pisa : 375 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Pisa : GSK Investigational Site Updated

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Pisa : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Pisa : 448 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Reggio Calabria : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Reggio Calabria : 445 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Roma : Università Cattolica del Sacro Cuore Policlinico "A. Gemelli"

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Roma : GSK Investigational Site Updated

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Roma : 311

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Roma : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Roma : 540 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Roma : 549 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Rome : Dipartimento di Neuroscienze, Unità Operativa di Neurologia Ospedale Bambin Gesù

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Siena : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Taranto : 542 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Torino : Azienda Universitatia Ospedaliera San Giovanni Battista

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Torino : 547 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Torrette di Ancona : GSK Investigational Site Updated

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Torrette di Ancona : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Trieste : 551 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Verona : Servizio di Neuropsichiatria Infantile Policlinico "G.B. Rossi" Borgo Roma

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Aichi : 154

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Aichi : GSK Investigational Site Updated

Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

Aomori : 132

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Aomori : 19

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Bunkyo : 309

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

View More »

Bunkyo : 184

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Bunkyou : 184

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Chiba : 160

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Chikushino : 159

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Daito : 21

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Ehime : GSK Investigational Site Updated

Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

Fujisawa : 152

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Fujisawa : 152

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Fujisawa : 12

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Fukuoka : 113

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Fukuoka : 155

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Fukuoka : 166

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Fukuoka : 112

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Fukuoka : 112

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Fukuoka : 166

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Fukuoka : GSK Investigational Site Updated

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

Fukuoka : GSK Investigational Site Updated

Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

Fukushima : 187

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Gifu : 107

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Gifu : 107

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Gifu : 107

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Hachioji : 163

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Hamamatsu : 124

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Hamamatsu : 14

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Higashimatsuyama : 118

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Higashimatsuyama : 118

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Higashiosaka : 175

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Himeji : 162

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Himeji : 11

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Hirosaki : 101

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Hiroshima : 177

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Hiroshima : 110

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Hiroshima : 303

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Hiroshima : 110

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Hiroshima : 23

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Hiroshima : GSK Investigational Site Updated

Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

Iizuka : 165

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Iwanuma : 151

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kagoshima : 142

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kagoshima : 156

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kagoshima : 143

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kagoshima : 143

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Kagoshima : 156

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Kagoshima : 8

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Kagoshima : GSK Investigational Site Updated

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

Kahoku-gun : 123

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kamakura : 20

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Kameda : 176

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kanagawa : GSK Investigational Site Updated

Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

Kashihara : 150

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kashiwakazi : 153

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Katori : 167

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kawasaki : 161

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kawasaki : 17

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Kitakusyu : 114

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kitakyusyu : 3

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Kobe : 108

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kobe : 108

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Kodaira : 120

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kodaira : 302

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Kodaira : 120

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Kodaira : 26

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Kodaira-city : 3

An Open Label Study of L059IV in Japanese Epilepsy Subjects With Partial Onset Seizures

Koga : 115

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kokubunji : 105

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kokubunji : 105

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Kokubunji : 9

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Koshi : 306

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Kurume : 141

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kyoto : 144

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kyoto : 32

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Kyoto : 16

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Miyagi : GSK Investigational Site Updated

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

Miyakonojo : 172

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Miyakonojo : 25

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Miyazaki : 181

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Miyazaki : 179

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Miyazaki : 186

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Moriyama : 136

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Moriyama : 136

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Nagoya : 189

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Nagoya : 145

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Nagoya : 305

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Nagoya : 305

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Nagoya Aichi : 5

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Nara : 182

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Nara :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Nara : 4

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Neyagawa : 125

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Niigata : 106

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Niigata : 301

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Niigata : 10

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Niigata : GSK Investigational Site Updated

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

Niigata : GSK Investigational Site Updated

Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

Nishinomiya : 173

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Ohmura : 116

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Ohmura : 116

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Okayama : 109

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Okayama : 109

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Okayama : 109

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Okayama : 22

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Okayama : GSK Investigational Site Updated

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

Onojo : 308

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Osaka : 174

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Osaka : 157

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Osaka : 171

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Osaka : 15

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Osaka : 27

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Osaka : GSK Investigational Site Updated

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

Osakasayama : 24

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Osaka-sayama : 129

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Otaru : 130

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Otaru : 130

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Otsu : 137

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Saitama : 178

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Saitama : 119

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Saitama : 119

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Saitama : 13

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Saito : 170

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Sakai : 147

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Sakai : 147

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Sakai : 1

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Sapporo : 131

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Sapporo : 117

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Sapporo : 304

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Sapporo : 117

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Sapporo : 304

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Sapporo : 117

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Sapporo : 304

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Sapporo : 29

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Sendai : 102

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Sendai : 103

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Sendai : 103

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Sendai : 102

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Sendai : 103

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Sendai : 6

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Shimajiri : 168

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Shimotsuke : 133

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Shimotsuke : 134

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Shimotsuke : 138

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Shimotsuke : 138

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Shinjuku : 148

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Shizuoka : 121

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Shizuoka : 307

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Shizuoka : GSK Investigational Site Updated

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

Shizuoka : GSK Investigational Site Updated

Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

Shizuoka-city : 2

An Open Label Study of L059IV in Japanese Epilepsy Subjects With Partial Onset Seizures

Suita : 169

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Suita : 149

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Takamatsu : 128

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Takatsuki : 140

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Takatsuki : 139

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Takatsuki : 139

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Tokyo : 190

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Tottori : 164

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Toyonaka : 146

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Toyonaka : 2

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Tsu : 135

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Tsu : 135

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Tsu : 28

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Ube : 111

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Ube : 111

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Ube : 7

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Yamagata : 104

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Yamagata : 18

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Yamagata-city, Yamagata : 4

An Open Label Study of L059IV in Japanese Epilepsy Subjects With Partial Onset Seizures

Yonago : 126

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Yonago : 127

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Yufu : 310

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Busan : 753 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Busan : 753 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Busan : 05

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Busan : 10

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Busan : 8

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

View More »

Busan : 9

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Busan : 14

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Daegu : 13

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Daegu : 12

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Daegu : 521

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Daegu : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Daejeon : 06

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Daejeon : 10

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Dajeon : 518

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Goyang-si : 08

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Goyang-si : 09

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Gwangju : 752 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Gwangju : 07

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Gwangju : 15

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Incheon : 7

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Kyunggi-do : 19

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seongnam-si : 14

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Seongnam-si : 11

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seoul :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Seoul : Seoul National University Hospital

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Seoul : Yonsei University College of Medicine Severance Hospital / Department of Pediatric Neurology

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Seoul : 751 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Seoul : 750 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Seoul : 754 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Seoul : GSK Investigational Site Updated

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

Seoul : 12

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Seoul : 13

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Seoul : 15

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Seoul : 03

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Seoul : 04

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Seoul : 11

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Seoul : 01

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Seoul : 02

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Seoul : 4

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seoul : 18

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seoul : 1

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seoul : 16

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seoul : 17

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seoul : 2

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seoul : 3

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seoul : 5

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seoul : 6

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seoul : Pfizer Investigational Site

Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures

Seoul : 520

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Seoul : 516

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Seoul : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Riga :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Riga :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Valmiera :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Valmiera :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Ipoh : Paediatric Department

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Kuala Lumpur : Hospital Kuala Lumpur

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Aguascalientes : 129 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Aguascalientes : 129 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Aguascalientes : 602

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Aguascalientes : 180 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Chihuahua : 185 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

View More »

Chihuahua : 183 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Ciudad Juarez : 184 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Culiacan : 101 Updated

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Culiacan : 127 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Culiacan : 127 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Guadalajara : 128 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Guadalajara : 126 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Guadalajara : 126 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Guadalajara : 128 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Guadalajara : Pfizer Investigational Site

Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures

Guadalajara : Pfizer Investigational Site Updated

Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures

Guadalajara : 189 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Mexico : Pfizer Investigational Site Updated

Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures

Mexico D.F. : 130 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Mexico D.F. : 130 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Mexico DF : 193 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Mexico DF : 195 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Mexico DF : 181 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Monterrey : 186 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Monterrey : 187 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Monterrey : 188 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Polanco : 125 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Polanco : 125 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Polanco : 182 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Puebla : 190 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

San Luis Potosi : 103 Updated

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

San Luis Potosi : 607

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Chishinau : IMSP Centrul National Stiintifico-Practic Medicina de Urgenta

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Heemstede : 401 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Heeze : 400 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Heeze : Epilepsiecentrum Kempenhaeghe

Rolandic Epilepsy/ESES/Landau-Kleffner Syndrome and Correlation With Language Impairment

Maastricht : Maastricht University Medical Center

Rolandic Epilepsy/ESES/Landau-Kleffner Syndrome and Correlation With Language Impairment

Oosterhout : 402 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Karachi : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Rawalpindi : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Cebu City : Cebu Doctors' University Hospital

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Manila : University of Santo Tomas Hospital

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Quezon City : Philippine Children's Medical Center

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Quezon City : St. Luke's Medical Center

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Sta. Cruz : Center for Neurodiagnostic and Therapeutic Services

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Bialystok : 475 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Bialystok : 792 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Bialystok : 404

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Bialystok : 792

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Czestochowa : 284 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

View More »

Dansk :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Gdansk : Klinika Neurologii Rozwojowej

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Gdansk : 403

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Gdansk : 286 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Gdańsk : "Klinika Neurologii Rozwojowej

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Gdynia : 282 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Goczalkowice Zdroj : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Katowice : 480 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Katowice : 478 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Katowice : 795 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Katowice : 478 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Katowice : 480 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Katowice :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Katowice : SAMODZIELNY PUBLICZNY SZPITAL KLINICZNY NR 6 ŚLĄSKIEJ AKADEMII MEDYCZNEJ W KATOWICACH GÓRNOŚLĄSKIE CENTRUM ZDROWIA DZIECKA I MATKI IM. JANA PAWŁA II Klinika Pediatrii i Neurologii Wieku Rozwojowego

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Katowice : 795

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Katowice : 334

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Katowice : 340

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Katowice : 288 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Katowice : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Krakow : 476 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Krakow : 793 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Krakow : 476 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Krakow : Krakowski Szpital, Specjalistyczny Im. Jana Pawła Ii W Krakowie

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Krakow :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Krakow : 793

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Krakow : 476

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Krakow :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Kraków : Centrum Neurologii Klinicznej

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Kraków : Instytut Neuromedica

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Kraków : WOJEWÓDZKI SPECJALISTYCZNY SZPITAL DZIECIĘCY im. ŚW. LUDWIKA W KRAKOWIE

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Kraków : Małopolskie Centrum Medyczne s.c.

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Kraków : Centrum Leczenia Padaczki i Migreny

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Lodz : NZOZ Polimedica

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Lodz : Centrum Terapii Współczesnej

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Łódź : Instytut "Centrum Zdrowia Matki Polki" Klinika Neurologii

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Lublin : Wojewódzki Szpital Specjalistyczny w Lublinie Oddzial Neurologii

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Lublin :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Lublin : 342

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Lublin :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Lublin : 283 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Olsztyn. :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Poznan : Katedra i Klinika Neurologii Wieku Rozwojowego

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Poznan : 477 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Poznan : 479 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Poznan : 479 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Poznan :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Poznan : NZOZ "NEURO - KARD,"Ilkowski I Partnerzy Spólka, Partnerska Lekarzy

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Poznan : AKADEMIA MEDYCZNA im. Karola Marcinkowskiego w Poznaniu Katedra I Klinika Neurologii Wieku Rozwojowego

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Poznan : 479

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Poznan : 341

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Szczecin : 407

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Szczecin : 338

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Szczecin : 289 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Warszawa : 794 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Warszawa :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Warszawa : Instytut Psychiatrii i Neurologii, II Klinika Neurologiczna

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Warszawa :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Warszawa : 794

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Warszawa : 343

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Warszawa : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Warszawa :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Warszawa : 287 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Warszawa : 281 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Amadora Amadora : Hospital Prof. Doutor Fernando Fonseca, EPE

Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA)

Coimbra : Hospital Pediátrico de Coimbra

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Coimbra : AIBILI - Centro de Estudos de Biodisponibildade

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Coimbra : 360

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Lisboa : Hospital Santa Maria

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

View More »

Lisboa : Hospital Dona Estefânia

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Lisboa : Hospital Francisco Xavier

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Lisboa : 365

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Lisboa : 362

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Lisbon : Centro Hospitalar de Lisboa Norte, EPE - Hospital de Staª Maria - Centro de Estudos Egas Moniz

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Lisbon : Centro Hospitalar de Lisboa Ocidental, EPE - Hospital Egas Moniz

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Matosinhos : Hospital Pedro Hispano

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Porto : Hospital Geral de Santo António

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Porto : Hospital Maria Pia

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Viana do Castelo : Unidade Local de Saúde de Alto Minho, EPE - Hospital de Santa Luzia - Serviço de Neurologi

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Vila Real : Centro Hospitalar de Trás-os -Montes e Alto-Douro, EPE - Hospital de São Pedro - Serviço de Neurologia

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Hato Rey : Hospital Del Maestro

Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures

Rio Piedras : Centro Neurodiagnostico

Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures

San Juan : 038 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

San Juan : 158 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Brasov : C.M.D.T.A. Neomed

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Bucharest : Clinica de Neurologie Peciatrica, Spitalul "Alexandru Obregia"

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Bucuresti : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Bucuresti : Cabinet Medical Individual "Dr. Roceanu Adina Maria" -Neurologie, Neurofiziologie (EEG, EMG, PEC)

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Bucuresti : 576

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

View More »

Campulung Muscel : Sc Clubul Sanatatii Srl

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Cluj Napoca : Clinical Hospital for children, Paediatric Neurology clinic

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Cluj-Napoca : 569

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Constanta : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Craiova; Jud. Dolj : Spitalul Clinic de Neuropsihiatrie Craiova

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Iasi : 570

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Sibiu : 571

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Sibiu : 577

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Targu Mures : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Targu Mures : 572

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Timisoara : Spitalul Clinic de Urgenta pentru copii Luis Turcanu, Clinica de Psihiatrie si Neurologie pentru copii si adolescenti

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Timisoara : 568

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Belgorod : GSK Investigational Site Updated

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Belgorod : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Kazan : 501 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Kazan : 506 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Kazan : GSK Investigational Site Updated

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

View More »

Kazan :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Kazan : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Kazan :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Krasnodar : GSK Investigational Site Updated

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Krasnodar : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Moscow : 502 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Moscow : 503 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Moscow : 507 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Moscow : 505 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Moscow : Moscow Research Institute of Pediatrics and Pediatric Surgery of Rosmedtechnology

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Moscow : Pediatric Scientific-practical Center of cranio-facial surgery and neurology

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Moscow : Research Center of Children Health of RAMS

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Moscow : GSK Investigational Site Updated

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Moscow :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Moscow : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Moscow :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Samara : GSK Investigational Site Updated

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Samara :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Samara : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Samara :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Smolensk : GSK Investigational Site Updated

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Smolensk : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

St Petersburg :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

St. Petersburg :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

St.-Petersburg : GSK Investigational Site Updated

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

St.-Petersburg : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Tyumen :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Tyumen :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Yaroslavi :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Yaroslavi :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Belgrade : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Belgrade : Child Neurology Service, Institute of Mother and Child Healthcare of Serbia "Dr. Vukan Cupic"

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Belgrade : Clinic of Neurology and Psychiatry for Children and Youth

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Belgrade : Clinic of Neurology, Clinical Center of Serbia

Eslicarbazepine Acetate Monotherapy Long Term Study

Belgrade : Clinic of Neurology, Clinical Center of Serbia

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

View More »

Nis : Clinical Centre Nis, Clinic of Children Internal Diseases, Child Neurology Department

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Novi Sad : Children Neurology Dept., Institute of Child- and Adolescent Health Care of Vojvodina

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Palmoticeva : Institute of Mental Health, Department of epilepsy and clinical neurophysiology

Eslicarbazepine Acetate Monotherapy Long Term Study

Palmoticeva : Institute of Mental Health, Department of epilepsy and clinical neurophysiology

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Bratislava : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Dolni Kubin : 594

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Dolny Kubin : Child Epileptology Out-patient

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Dubnica nad Vahom : 598

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Hlohovec : 596

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

View More »

Krompachy : 600

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Liptovský Mikuláš : Tempus, s.r.o.Child Epileptology Ambulance

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Tornala : 599

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Zilina : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Zilina : 601

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Cape Town :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Cape Town :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Alicante : 415

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Almeria : 525 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Almeria : 592 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Almeria : 325 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Badalona :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

View More »

Badalona : 422

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Badalona :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Bajo Sevilla : 597 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Barcelona : 528 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Barcelona : 529 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Barcelona : 528 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Barcelona : 529 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Barcelona :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Barcelona : Hospital Vall Hebron

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Barcelona : Hospital Universitari Vall d'Hebron

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Barcelona : Hospital de la Santa Creu i Sant Pau

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Barcelona : IMAS Hospital del Mar

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Barcelona : 413

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Barcelona : 590 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Esplugues de Llobregat : Hospital Sant Joan de Déu, Dep. Neuropediatría

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Girona : 417

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Granada : Hospital Materno Infantil Virgen de las Nieves

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Granada :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Granada :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

La Laguna : 419

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Las Palmas de Gran Canaria : 412

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Madrid :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Madrid : Hospital Clínico San Carlos, Servicio de Neurología Pediátrica

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Madrid : 306

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Madrid : Hospital Clínico San Carlos

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Madrid : Hospital General Universitario Gregorio Marañón

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Madrid : 416

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Madrid :

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Madrid : Spain, Madrid

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Murcia - El Palmar :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Murcia (El Palmar) : 421

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Palma de Mallorca : Hospital Son Dureta, Dep. Neuropediatría

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Palma de Mallorca : 301

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Palma de Mallorca : 591 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

San Sebastian : 418

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

San Sebastian de los Reyes : 595 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Santa Cruz De Tenerife : 324 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Santander :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Santander : 304

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Santiago de Compostela : Hosital Clínico Universario, Dep. Neuropediatría

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Santiago de Compostela : 20 Updated

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

Santiago de Compostela : 414

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Santiago de Compostela : 596 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Sevilla :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Sevilla : Hospital Universitario Virgen Macarena

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Sevilla : Spain, Andalucia

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Terrassa : Spain, Terassa

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Terrassa : 598 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Valencia : 527 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Valencia : 527 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Valencia :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Valencia : 594 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Valladolid : 526 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Valladolid : 599 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Zaragoza : Hospital Universitario Miguel Servet

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Goteborg : 551 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Goteborg : 551 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Göteborg : 440

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Helsingborg : 443

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Motala : 441

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

View More »

Stockholm : 550 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Stockholm : 550 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Stockholm : 438

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Umea : 442

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Taichung : 801 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Tainan : 804 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Tainan : 800 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Taipei : GSK Investigational Site

Crossover Study to Evaluate the Pharmacokinetics of Ezogabine/Retigabine in Taiwanese Subjects

Bangkok : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Bangkok : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Khon Kaen : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Muang : Pfizer Investigational Site Updated

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Songkla : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Adana : 713 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Ankara : 714 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Eskisehir : 710 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Istanbul : 715 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Istanbul : 719 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

View More »

Istanbul : 711 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Izmir : 717 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Manisa : 716 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Trabzon : 718 Updated

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Chernihiv : 622

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Dnepropetrovsk :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Dnepropetrovsk : Pediatric Clinical Hospital No. 5, Department of Pediatric Neurology

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Dnepropetrovsk : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Dnipropetrovsk : Communal Institution "Dnipropetrovsk Regional Clinical Hospital named after l.l. Mechnikov" Regional Center of psychosomatic disorders, Psychoneurology department for patients with psychosomatic disorders and borderline conditions

Eslicarbazepine Acetate Monotherapy Long Term Study

View More »

Dnipropetrovsk : Communal Institution "Dnipropetrovsk Regional Clinical Hospital named after l.l. Mechnikov" Regional Center of psychosomatic disorders, Psychoneurology department for patients with psychosomatic disorders and borderline condtions

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Dnipropetrovsk : 628

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Donetsk : Communal Medical and Preventive Treatment Institution "Regional Clinical Psychiatric Hospital" Donetsk National Medical University

Eslicarbazepine Acetate Monotherapy Long Term Study

Donetsk : Communal Medical and Preventive Treatment Institution "Regional Clincal Psychiatric Hospital" Donetsk National Medical University

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Donetsk : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Kharkiv : Institute of Neurology, Psychiatry and Narcology, AMS of Ukraine Acad.

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Kharkiv : State Institution "Institute of neurology, psychiatry, and narcology of AMS of Ukraine" Department of cerebrovascular patology

Eslicarbazepine Acetate Monotherapy Long Term Study

Kharkiv : State Institution "Institute of neurology, psychiatry and narcology of AMS of Ukraine" Department of cerebrovascular patology

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Kharkov :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Kharkov : State Treatment and Prevention Institution " Central clinical hospital of Ukrzalizntysya" Neurology Department of Neuropathology and Child Neurology

Eslicarbazepine Acetate Monotherapy Long Term Study

Kharkov : State Institution "Institute of the Health Care of Children and Adolescents of Academy of Medical Sciences of Ukraine Dept of Psych

Eslicarbazepine Acetate Monotherapy Long Term Study

Kharkov : State Treatment and Prevention Institution

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Kharkov : State Institution "Institute of the Health Care of Children & Adolescents of Academy of Medical Sciences of Ukraine" Dept of Psychiatry

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Kharkov : 626

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Kiev : Ukrainian Medical Rehabilitation Centre for Children with Organic Disorders of Nervous System

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Kiev : State Institution Railway Clinical Hospital #1 of Kiev Railway Station of DTGO South Western Railroad Psycho-neurological Department

Eslicarbazepine Acetate Monotherapy Long Term Study

Kiev : State Institution Railway Clinical Hospital #1 of Kiev Railway Station of DTGO South Western Railroad Psycho-neurological Department

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Kyiv : 629

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Kyiv : 630

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Lugansk : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Luhansk : 621

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Lviv :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Lviv : Communal Institution "Lviv Regional Clinical Psych Hospital"

Eslicarbazepine Acetate Monotherapy Long Term Study

Lviv : Communal Institution "Lviv Regional Clinical Psychiatric Hospital" Department #20, Lviv National Medical University, named after Danylo

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Lviv : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Odesa : 625

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Odesa : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Odessa :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Odessa : Communal Institution "Odessa Regional Clinical Psych Hospital #1" Department of Day Care

Eslicarbazepine Acetate Monotherapy Long Term Study

Odessa : Communal Institution "Odessa Regional Clinical Psych Hospital #1" Department of Day Care

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Oleksandrivka village, Odesa : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Poltava : Poltava Regional Clinical Psychiatric Hospital named O.F. Maltsev

Eslicarbazepine Acetate Monotherapy Long Term Study

Poltava : Poltava Regional Clinical Psychiatric Hospital named O.F. Maltsev

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Poltava : GSK Investigational Site Updated

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Simferopol : Crimean Republican Institution "Clinical Psychiatric Hospital #1"

Eslicarbazepine Acetate Monotherapy Long Term Study

Simferopol : Crimean Republic Institution "Clinical Psychiatric Hospital #1"

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Simferopol : 632

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Vinnytsia : Communal Institution "Vinnystsia Regional Psycho-Neurological Hospital named after O.I. Yuschenko, Vinnytsia National Medical University named after M.I. Pirogov, Dispensary department, Department of Psychiatry and Addictology

Eslicarbazepine Acetate Monotherapy Long Term Study

Vinnytsia : Communal Institution "Vinnytsia Regional Psycho-Neurological Hospital named after O.I. Yuschenko, Vinnytsia National Medical University named after M.I. Pirogov, Dispensary department, Department of Psychiatry and Addictology

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Bedford : Southampton General Hospital

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Birmingham : 603 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Birmingham : Birmingham Children's Hospital

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Birmingham : 466

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Blackpool : 360 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

View More »

Crawley : Crawley Hospital

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Leeds : Department of Paediatric, Clarendon Wing, Leeds General Infirmary

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Leicester : Leicester Royal Infirmary

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Liverpool : 464

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

London : 600 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

London : Great Ormond Street Hospital

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

London : The Royal London Hospital

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

London : St Georges Hospital, Child Development

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

London : 468

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

London : 364 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

London : 369 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Middlesborough : 605 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Middlesborough : 363 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Morriston : 602 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Morriston : 602 Updated

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Oxford : 365 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Sheffield : The Ryegate Chilldren's Centre

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Stoke on Trent : 368 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Swansea : 465

Study Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects Aged 16 Years and Older

Truro : 601 Updated

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Truro : 367 Updated

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Washington : 002 Updated

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures